K. Aigner (Linz, Austria)
Accuracy of CT-guided transthoracic needle biopsy of lung lesions: results of 612 consecutive procedures
S. Novello, A. Priola, S. Priola, M. Longo, M. Giaj Levra, A. Cataldi, G. Garofalo, C. Fava, G. V. Scagliotti (Orbassano, Italy)
|   |
Contribution of FDG-PET on staging and management of NSCLC planned for concomitant chemoradiotherapy
M. Diakopoulou, O. Brodin, K. G. Kolbeck (Stockholm, Sweden)
| |
Audit of adherence to NICE guidelines on investigation of lung cancer – CT before bronchoscopy
G. Hands, T. Win (Syevenage, United Kingdom)
| |
Should we routinely assess patient experience of fibreoptic bronchoscopy?
A. Hardy, D. Ford (Scarborough, United Kingdom)
| |
Clinical value of 18-FDG PET-CT in mediastinal lymph node staging in non-small cell lung cancer (NSCLC) patients with previous cN0-1 on CT
J. Sayas Catalán, R. Alonso Moralejo, M. Coronado Poggio, F. Pozo Rodríguez, J. L. Martin de Nicolás, A. López-Encuentra (Madrid, Spain)
| |
Endobronchial and endoscopic ultrasound for assessment of PET positive mediastinal lymph nodes
R. Rintoul, R. Buttery, C. Hardy, D. Rassl, N. Carroll (Cambridge, United Kingdom)
| |
The correlation between mediastinal lymphadenopathy positivity proved by mediastinoscopy and serum levels of vascular endothelial growth factor (VEGF) and carcinoembryonic antigen (CEA) in NSCLC cases
B. Kocar, K. Murat, T. Huseyin Cem, E. Artan, T. Karadeli, O. Hayati, S. Cikrikcioglu (Istanbul, Turkey)
| |
Does CT scan improve diagnostic yield of bronchoscopy done for lung cancer?
A. Gulati, A. Thomas, P. Hawkins (Norfolk, Suffolk, Essex, United Kingdom)
| |
Positron emission tomography scanning in staging lung cancer: audit of early experience in a UK district general hospital
C. Snelson, M. Holmes, J. McAdam, K. Srinivasan, H. Moudgil (Telford, United Kingdom)
| |
The impact of specialist lung cancer clinics on government targets in patients referred with suspected lung cancer in the University Hospital of North Staffordshire, UK
M. Iqbal, I. Hussain (Oxford, Stoke-on-Trent, United Kingdom)
| |
Re-audit of adherence to NICE guidelines on investigation of lung cancer
J. Cannon, C. Prendergast, T. Win (Stevenage, United Kingdom)
| |
Is virtual bronchoscopy (VB) useful in diagnosing of peripheral lung cancer?
P. Radwan-Rohrenschef, B. Burakowska, J. Kus, I. Bestry (Warsaw, Poland)
| |
Detection of neuroendocrine tumors in the lungs using 99mTc somatostatin receptors scintigraphy
V. Artiko, V. Obradovic, N. Petrovic, B. Popovic, D. Macut, M. Petakov, I. Bozic, T. Isailovic, S. Damjanovic (Belgrade, Serbia And Montenegro)
| |
Is it useful performing pathology analysis on all samples from bronchoscopically accessible lung tumours?
G. Jifon, D. Butterworth, M. Winson (Crewe, United Kingdom)
| |
Scintigraphic detection of neuroendocrine tumors in the lungs using 111in-pentetreotide
V. Obradovic, V. Artiko, N. Petrovic, B. Popovic, D. Macut, M. Petakov, I. Bozic, T. Isailovic, S. Damjanovic (Belgrade, Serbia And Montenegro)
| |
Imaging guided pleural biopsies in unexplained pleural effusions
A. Gulati, N. Mani, D. A. Promnitz (Ipswich, United Kingdom)
| |
Evaluation of concomitant pleural effusions in patients with lung cancers
N. Karatas, E. Gulec, P. Arbak, A. N. Annakkaya (Duzce, Turkey)
| |
Yield of biopsy, brushing and bronchial washing through fiberoptic bronchoscopy in the diagnosis of lung cancer with visible lesions
M. I. Saleem, M. Uzbeck, V. Parihar, A. McIntyre, J. J. Gilmartin (Galway, Ireland)
| |
The rate of transudate in tumor-associated pleural effusions
T. Gonlugur, U. Gonlugur (Sivas, Turkey)
| |
Factors affecting the duration from diagnosis to treatment in patients with lung cancer
N. Yaman, A. Gulcu, P. Celik, B. Cengiz Ozyurt, N. Nese, A. Sakar Coskun, A. Yorgancioglu (Manisa, Turkey)
| |